Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2013, Journal of Excipients and Food Chemicals
Journal of Excipients and Food Chemicals
Excipient counterion dependent mechanisms in Pharmaceutical Development: a review2011 •
Biotechnology: Pharmaceutical Aspects
Solvent Systems for Crystallization and Polymorph SelectionBioavailability is the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. Traditionally, nearly 40% of the new chemical entities (NCEs) identified by pharmaceutical industry screening programs have failed to be developed due to of poor water solubility, which makes their formulation difficult or even impossible to come into the regular market. Solubility is one of the important ways to achieve the desired concentration of drug in to the systemic circulation for its pharmacological response and also most of the drugs are weakly acidic and weakly basic with poorly aqueous solubility. The oral route of administration is the most preferred and widely acceptable route of delivery due to ease of ingestion for many drugs, however these drugs with slow dissolution rate and low solubility in aqueous media shows the incomplete absorption leading to low bioavailability when orally administered. Poorly aqueous soluble drugs often require high doses in order to reach therapeutic plasma concentrations of oral concentration because of which increase in the side effects for certain drugs. Pharmaceuticals falling under the Biopharmaceutics Classification System (BCS) class II and IV are the main emphasis of this review as these drugs are of low solubility. Here we discussed about traditional techniques, novel drug delivery technologies, solid dispersion techniques and vascular approaches to enhance the solubility as well as the bioavailability of low soluble drugs.
Clofazimine, a lipophilic (log P = 7.66) riminophenazine antibiotic approved by the US Food and Drug Administration (FDA) with a good safety record, was recently identified as a lead hit for cryptosporidiosis through a high-throughput phenotypic screen. Cryptosporidiosis requires fast-acting treatment as it leads to severe symptoms which, if untreated, result in morbidity for infants and small children. Consequently, a fast-releasing oral formulation of clofazimine in a water-dispersible form for pediatric administration is highly desirable. In this work, clofazimine nanoparticles were prepared with three surface stabilizers, hypromellose acetate succinate (HPMCAS), lecithin, and zein, using the flash nanoprecipitation (FNP) process. Drug encapsulation efficiencies of over 92% were achieved. Lyophilization and spray-drying were applied and optimized to produce redispersible nanoparticle powders. The release kinetics of these clofazimine nanoparticle powders in biorelevant media were measured and compared with those of crystalline clofazimine and the currently marketed formulation Lamprene. Remarkably improved dissolution rates and clofazimine supersaturation levels up to 90 times equilibrium solubility were observed with all clofazimine nanoparticles tested. Differential scanning calorimetry indicated a reduction of crystallinity of clofazimine in nanoparticles. These results strongly suggest that the new clofazimine nanoparticles prepared with affordable materials in this low-cost nanoparticle formulation process can be used as viable cryptosporidiosis therapeutics.
American Journal of Advanced Drug Delivery
Silica-Lipid Hybrid Microparticles for Improved Bioavailability of Bcs Class IV DrugsInternationale Pharmaceutica Sciencia
A Concise Review on Methods of Solubility EnhancementNew Journal of Chemistry
Drug specific, tuning of an ionic liquid's hydrophilic–lipophilic balance to improve water solubility of poorly soluble active pharmaceutical ingredients2013 •
Excipient Selection In Parenteral Formulation Development
Excipient Selection In Parenteral Formulation Development2013 •
Pharmaceutical Technology
A Review and Classification of Emerging Excipients in Parenteral Medications2003 •
European Journal of Pharmaceutics and Biopharmaceutics
Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process2003 •
International Journal of Pharmacy and Pharmaceutical Sciences, Innovare Academic Sciences, Sep 1
INSIGHTS INTO FORMULATION TECHNOLOGIES AND NOVEL STRATEGIES FOR THE DESIGN OF ORALLY DISINTEGRATING DOSAGE FORMS: A COMPREHENSIVE INDUSTRIAL REVIEW2019 •
2018 •
Acta Amazonica
Caracterização físico-química das misturas binárias de biodiesel e diesel comercializados no Amazonas2009 •
Journal of Inclusion Phenomena and Macrocyclic Chemistry
Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-β-cyclodextrin2010 •
Journal of Pharmaceutical Sciences
A Laminated Polymer Film Formulation for Enteric Delivery of Live Vaccine and Probiotic Bacteria2014 •
Recent Patents on Drug Delivery & Formulation
Recent Trends in Oral Drug Delivery: A Review2009 •
European Journal of Pharmaceutics and Biopharmaceutics
Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques2005 •
Journal of Pharmaceutical Sciences
Assessing the performance of amorphous solid dispersions2012 •
2010 •
Advanced Drug Delivery Reviews
Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development2011 •
Journal of Excipients and Food Chemicals
Excipient-API interactions in dry powder inhalers2012 •